A framework for assessing interactions for risk stratification models: the example of ovarian cancer is a research paper published in JNCI Journal of the National Cancer Institute (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Ovarian Cancer Research Fund
Grant: PPD/RPCI.07
National Cancer Institute
Grant: U19-CA148112
Wellcome Trust
Grant: 076113
The genetics of weight, BMI, adiposity and obesity
National Institutes of Health
Grant: CA1X01HG007491-01
National Institutes of Health
Grant: R01-CA149429
National Institutes of Health
Grant: R01-CA058598
Canadian Institutes of Health Research
Grant: MOP-86727
Army Medical Research and Materiel Command
Grant: DAMD17-01-1-0729
National Health & Medical Research Council of Australia
Grant: 199600
Towards cancer control: Population and molecular strategies
National Health & Medical Research Council of Australia
Grant: 400413
Australian Ovarian Cancer Study (AOCS): A multidisciplinary ovarian cancer resource for the genomic era
National Health & Medical Research Council of Australia
Grant: 400281
Molecular Epidemiology of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core
NCI NIH HHS
Grant: K07 CA095666
NCI NIH HHS
Grant: K22 CA138563
NCI NIH HHS
Grant: R01 CA083918
NCI NIH HHS
Grant: R01 CA126841
NCI NIH HHS
Grant: R01 CA149429
NCI NIH HHS
Grant: P30 CA072720
NCI NIH HHS
Grant: P50 CA105009
NCI NIH HHS
Grant: R01 CA087538
NCI NIH HHS
Grant: R01 CA112523
NCRR NIH HHS
Grant: M01 RR000056
NCI NIH HHS
Grant: R01 CA058860
NCI NIH HHS
Grant: R01 CA095023
NCI NIH HHS
Grant: U19 CA148112
NCI NIH HHS
Grant: K07 CA080668
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA054419
NCI NIH HHS
Grant: R01 CA058598
National Institutes of Health
Grant: 5R01CA054419-14
Genes, Hormones &Environment in an Ovarian Cancer Model
National Institutes of Health
Grant: 5R01CA040214-03
FUNCTIONAL CHARACTERIZATION OF ISOLATED PDGF RECEPTOR
European Commission
Grant: 223175
Collaborative Oncological Gene-environment Study
National Institutes of Health
Grant: 5R03CA115195-02
Ovarian Cancer and Gonadotropin Signaling
National Institutes of Health
Grant: 5K07CA080668-06
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS
National Institutes of Health
Grant: 5R01CA126841-04
Regulatory T Cell Function in Ovarian Cancer
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: N01CN025403-000
SURVEILLANCE EPIDEMIOLOGY AND END RESULTS
National Institutes of Health
Grant: 1P50CA159981-01A1
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
National Institutes of Health
Grant: N01PC067010-000
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAM
National Institutes of Health
Grant: 5R01CA087538-02
Epidemiology of Ovarian Cancer:New Hypotheses
National Institutes of Health
Grant: N01CN055424-007
SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER)
National Institutes of Health
Grant: N01PC067001-001
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5K22CA138563-02
Obesity in ovarian cancer prognosis
National Institutes of Health
Grant: 5F32CA007491-03
EFFECT OF TRANSFORMATION ON REGULATION OF GM3 SYNTHETASE
National Institutes of Health
Grant: 5R01CA083918-04
ESTROGEN, DIET, GENETICS AND ENDOMETRIAL CANCER
National Institutes of Health
Grant: 1K07CA095666-01A1
Phytoestrogens, alcohol, and endometrial cancer risk
National Institutes of Health
Grant: 1R01CA061132-01
CASE-CONTROL STUDY OF OVARIAN CANCER IN LOS ANGELES
National Institutes of Health
Grant: 1R03CA113148-01
The Progesterone Receptor Gene and Ovarian Cancer Risk
National Institutes of Health
Grant: 5R01CA112523-03
Steroid Hormone Genes and Ovarian Cancer Risk
National Institutes of Health
Grant: 3P30CA046592-31S7
Cancer Center Support Grant 2018-2023
National Institutes of Health
Grant: 5P50CA105009-02
Core--Tissue Banking and Pathology
National Institutes of Health
Grant: 2P01CA017054-17
USC CANCER CENTER EPIDEMIOLOGY &BIOSTATISTICS UNIT
National Institutes of Health
Grant: 5R01CA149429-05
The Mitochondrial Genome and Ovarian Cancer Risk
National Institutes of Health
Grant: 5R01CA058860-02
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES
National Institutes of Health
Grant: 5R01CA095023-03
Inflammation and Ovarian Cancer
National Institutes of Health
Grant: 3U19CA148112-04S1
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
National Institutes of Health
Grant: 3P30CA072720-07S2
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 3P30CA014089-17S1
USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
National Institutes of Health
Grant: 5R01CA058598-05
COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPS
AstraZeneca
Cancer Foundation of Western Australia
NHGRI NIH HHS
National Cancer Institute
Ovarian Cancer Research Fund
National Human Genome Research Institute
Ovarian Cancer Association Consortium
Cancer Councils of New South Wales
Wellcome Trust
FWCI
0.59
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals